Clyde W Yancy Selected Research

Hydralazine (Apresoline)

1/2018	Timing of Postdischarge Follow-Up and Medication Adherence Among Patients With Heart Failure.
2/2016	Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry.
12/2014	G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT.
8/2013	Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
6/2013	Nitrate therapy for heart failure: benefits and strategies to overcome tolerance.
8/2009	Isosorbide dinitrate and hydralazine as therapy for African Americans with heart failure; a failed paradigm?
2/2009	Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
8/2007	Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).
4/2007	Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
8/2005	Treatment of the African-American patient with congestive heart failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clyde W Yancy Research Topics

Disease

177	Heart Failure 01/2022 - 01/2002
21	Atrial Fibrillation 01/2022 - 12/2003
11	Left Ventricular Dysfunction 08/2016 - 01/2004
10	Myocardial Infarction 01/2021 - 04/2004
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 07/2004
6	Hypertension (High Blood Pressure) 01/2022 - 04/2008
6	Stroke (Strokes) 01/2021 - 01/2013
6	Renal Insufficiency (Renal Failure) 01/2016 - 01/2006
5	Cardiomyopathies (Cardiomyopathy) 01/2021 - 08/2008
5	Chronic Renal Insufficiency 01/2021 - 01/2016
5	Systolic Heart Failure 01/2014 - 01/2004
4	COVID-19 01/2022 - 01/2021
4	Hypotension (Low Blood Pressure) 08/2016 - 07/2004
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 08/2006
3	Type 2 Diabetes Mellitus (MODY) 11/2020 - 12/2019
3	Neoplasms (Cancer) 11/2020 - 08/2006
3	Diabetes Mellitus 12/2017 - 01/2016
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 02/2011 - 10/2008
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Myocarditis (Carditis) 10/2021 - 10/2018
2	Edema (Dropsy) 01/2020 - 02/2012
2	Acute Kidney Injury (Acute Renal Failure) 12/2017 - 03/2013
2	Sudden Death 12/2017 - 12/2009
2	Thrombosis (Thrombus) 06/2011 - 05/2007
1	Premature Menopause 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Obesity 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2021
1	Death (Near-Death Experience) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Fibrosis (Cirrhosis) 01/2020

Drug/Important Bio-Agent (IBA)

30	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 01/2002
21	Angiotensin Receptor AntagonistsIBA 01/2022 - 10/2005
17	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 01/2005
15	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2019 - 10/2003
11	Hydralazine (Apresoline)FDA LinkGeneric 01/2018 - 06/2002
9	SodiumIBA 01/2022 - 01/2002
9	sacubitril and valsartan sodium hydrate drug combinationIBA 12/2021 - 08/2016
9	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 01/2018 - 06/2002
8	CreatinineIBA 01/2017 - 07/2006
7	Natriuretic PeptidesIBA 01/2019 - 09/2004
5	Vasopressins (Vasopressin)IBA 01/2019 - 01/2005
5	DiureticsIBA 03/2013 - 12/2004
4	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 01/2016
4	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 10/2018 - 10/2003
4	Digoxin (Digitek)FDA LinkGeneric 01/2016 - 08/2005
3	CholesterolIBA 01/2022 - 12/2008
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2021
3	Sodium-Glucose Transport ProteinsIBA 11/2020 - 12/2019
3	Pharmaceutical PreparationsIBA 08/2016 - 08/2008
3	Tolvaptan FDA Link 10/2015 - 01/2013
3	Vasodilator Agents (Vasodilators)IBA 07/2008 - 01/2006
2	dapagliflozinIBA 01/2022 - 11/2020
2	Biological ProductsIBA 01/2022 - 10/2021
2	CalciumIBA 11/2021 - 01/2019
2	VaccinesIBA 10/2021 - 01/2018
2	Enalapril FDA LinkGeneric 01/2020 - 08/2016
2	Hypoglycemic Agents (Hypoglycemics)IBA 12/2019 - 01/2016
2	GTP-Binding Proteins (G-Protein)IBA 07/2019 - 12/2014
2	Fibroblast Growth Factor-23IBA 01/2019 - 01/2018
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019 - 12/2003
2	NitratesIBA 06/2013 - 02/2009
2	AnticoagulantsIBA 05/2012 - 04/2011
2	Dabigatran FDA Link 03/2011 - 03/2011
2	Warfarin (Coumadin)FDA LinkGeneric 03/2010 - 02/2009
2	AldosteroneIBA 04/2009 - 01/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2006 - 08/2005
2	Carvedilol (Coreg)FDA LinkGeneric 07/2004 - 05/2004
1	Cystatin CIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	mRNA VaccinesIBA 10/2021
1	SolutionsIBA 01/2021
1	benzoyl L-arginine methyl ester (BAME)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Prealbumin (Transthyretin)IBA 12/2020
1	N- benzhydryl- 5- (2- (methylamino)propanamido)- 3- (3- methylbutanoyl)- 6- oxodecahydropyrrolo(1,2- a)(1,5)diazocine- 8- carboxamideIBA 11/2020
1	GadoliniumIBA 01/2020

Therapy/Procedure

95	Therapeutics 01/2022 - 05/2002
27	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2017 - 01/2005
19	Cardiac Resynchronization Therapy 02/2019 - 01/2005
15	Length of Stay 01/2022 - 07/2004
11	Patient Readmission 01/2022 - 04/2008
5	Drug Therapy (Chemotherapy) 01/2022 - 04/2004
4	Heart Transplantation (Grafting, Heart) 01/2021 - 05/2005
4	Lung Transplantation 04/2009 - 09/2005
3	Heart-Assist Devices 01/2019 - 09/2016
3	Percutaneous Coronary Intervention 01/2014 - 11/2011
3	Contraindications 06/2013 - 01/2004
3	Drug-Eluting Stents 11/2011 - 05/2007
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2019
2	Transitional Care 11/2017 - 01/2016
1	Glycemic Control 01/2022
1	Subacute Care 12/2020
1	Catheter Ablation 12/2020